Updated Earnings Note (December 31, 2007)

The agreement provides that, subject to certain closing conditions, including a an Israeli tax ruling, ARP will sell 12.5% of stock the company’s subsidiary, GammaCan, Ltd. As a result, the company will own 100% of the shares of its subsidiary. GammaCan International agreed to issue to ARP 2.7 million shares of its common stock, a warrant to acquire 1,123,973 shares of its common stock and an additional warrant to acquire 449,589 shares of its common stock.

Both warrants are exercisable for five years at an exercise price equal to the average last sales price of the company’s common stock during the sixty trading days prior to November 26, 2007.

In connection with agreement, ARP and the company’s subsidiary agreed to enter into an amendment of the sale of intellectual property agreement originally entered into by the subsidiary and ARP on June 11, 2004, which specifically delineates clarity of title and related issues to certain intellectual property sold under the original sale of intellectual property agreement.

The company and ARP also agreed to enter into a lock-up agreement whereby ARP agreed not to effect any transfer of any of the securities (and any underlying securities) to be issued under the agreement until May 26, 2009 unless there is a change of control or the transfer is to a permitted transferee. Following such date, ARP will be permitted to sell up to one-sixth of the locked-up securities over the following six months such that at the end of such six month period (twenty-four months following closing), the locked-up securities will no longer be subject to a lock-up.

*The information and statistical data contained herein have been obtained from sources, which we believe to be reliable but in no way are warranted by us as to accuracy or completeness. We do not undertake to advise you as to changes in figures or our views. This is not a solicitation of any order to buy or sell. Taglich Brothers, Inc. is fully disclosed with its clearing firm, Pershing, LLC, is not a market maker and does not sell to or buy from customers on a principal basis. The above statements are the opinion of Taglich Brothers, Inc. and are not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. There may be instances when fundamental, technical and quantitative opinions contained in the reports are not in concert. We, our affiliates, any officer, director or stockholder or any member of their families may from time to time purchase or sell any of the above-mentioned or related securities. Analysts and members of the Research Department are prohibited from buying or selling securities issued by the companies that Taglich Brothers, Inc. has a research relationship with, except if ownership of such securities was prior to the start of such relationship, then an Analyst or member of the Research Department may sell such securities after obtaining expressed written permission from the Director of Research. As of the date of this report, no officers or employees of Taglich Brothers, Inc. owned any of the company’s stock. All research issued by Taglich Brothers, Inc. is based on public information. Taglich Brothers, Inc. does not currently have an Investment Banking relationship with the company mentioned and was not a manager or co-manager of any offering for the company within the last three years. The company paid for the creation and dissemination of research reports for the first year a monetary fee of $24,000 (USD) in July, 2007, and after the first year of publication will pay a monthly monetary fee of $2,000 (USD) to Taglich Brothers, Inc. for the creation and dissemination of research reports. For further information and Taglich Brothers, Inc. ownership data please refer to each individual report.

To send this page to a friend, just fill out the form below and press the "send it" button!